{
    "mtblsStudy": {
        "studyStatus": "Public",
        "curationRequest": "MANUAL_CURATION",
        "modifiedTime": "2019-06-21T12:10:26.113000",
        "statusUpdateTime": "2019-06-21T12:10:26.113000",
        "read_access": true,
        "write_access": false,
        "is_curator": false
    },
    "isaInvestigation": {
        "comments": [
            {
                "name": "Created With Configuration",
                "value": "C:UsersUUDocumentsStephanieISAcreatorMetaboLightsConfigurationsMetaboLightsConfig20150707"
            },
            {
                "name": "Last Opened With Configuration",
                "value": "MetaboLightsConfig20150707"
            }
        ],
        "identifier": "MTBLS749",
        "title": "Investigation",
        "description": "",
        "submissionDate": "2018-09-18",
        "publicReleaseDate": "2019-06-21",
        "filename": "",
        "people": [],
        "publications": [],
        "ontologySourceReferences": [
            {
                "comments": [],
                "name": "HRDO",
                "file": "http://data.bioontology.org/ontologies/HRDO",
                "version": "2",
                "description": "Disease core ontology applied to Rare Diseases"
            },
            {
                "comments": [],
                "name": "OBI",
                "file": "http://data.bioontology.org/ontologies/OBI",
                "version": "22",
                "description": "Ontology for Biomedical Investigations"
            },
            {
                "comments": [],
                "name": "NCBITAXON",
                "file": "http://data.bioontology.org/ontologies/NCBITAXON",
                "version": "2",
                "description": "National Center for Biotechnology Information (NCBI) Organismal Classification"
            },
            {
                "comments": [],
                "name": "BTO",
                "file": "http://data.bioontology.org/ontologies/BTO",
                "version": "22",
                "description": "BRENDA Tissue and Enzyme Source Ontology"
            },
            {
                "comments": [],
                "name": "MS",
                "file": "http://data.bioontology.org/ontologies/MS",
                "version": "86",
                "description": "Mass Spectrometry Ontology"
            },
            {
                "comments": [],
                "name": "EDAM",
                "file": "http://data.bioontology.org/ontologies/EDAM",
                "version": "19",
                "description": "EDAM bioinformatics operations, data types, formats, identifiers and topics"
            },
            {
                "comments": [],
                "name": "BRO",
                "file": "http://data.bioontology.org/ontologies/BRO",
                "version": "14",
                "description": "Biomedical Resource Ontology"
            },
            {
                "comments": [],
                "name": "MMO",
                "file": "http://data.bioontology.org/ontologies/MMO",
                "version": "37",
                "description": "Measurement Method Ontology"
            },
            {
                "comments": [],
                "name": "EFO",
                "file": "http://data.bioontology.org/ontologies/EFO",
                "version": "113",
                "description": "Experimental Factor Ontology"
            },
            {
                "comments": [],
                "name": "MTBLS",
                "file": "https://www.ebi.ac.uk/metabolights/",
                "version": "1.0",
                "description": "Metabolights Ontology"
            },
            {
                "comments": [],
                "name": "CHMO",
                "file": "",
                "version": "2019-06-21",
                "description": ""
            }
        ],
        "studies": [
            {
                "comments": [],
                "identifier": "MTBLS749",
                "filename": "s_MTBLS749.txt",
                "title": "Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington\u2019s disease subjects",
                "description": "Huntington's disease (HD) is a severe neurological disease leading to psychiatric symptoms, motor impairment and cognitive decline. The disease is caused by a CAG expansion in the huntingtin (HTT) gene, but how this translates into the clinical phenotype of HD remains elusive. Using liquid chromatography mass spectrometry, we analyzed the metabolome of cerebrospinal fluid (CSF)\u00a0from premanifest and manifest HD subjects as well as control subjects. Inter-group differences revealed that the tyrosine metabolism, including tyrosine, thyroxine, L-DOPA and dopamine, was significantly altered in manifest compared with premanifest HD. These metabolites demonstrated moderate to strong associations to measures of disease severity and symptoms. Thyroxine and dopamine also correlated with the five year risk of onset in premanifest HD subjects. The phenylalanine and the purine metabolisms were also significantly altered, but associated less to disease severity. Decreased levels of lumichrome were commonly found in mutated HTT carriers and the levels correlated with the five year risk of disease onset in premanifest carriers. These biochemical findings demonstrates that the CSF metabolome can be used to characterize molecular pathogenesis occurring in HD, which may be essential for future development of novel HD therapies.",
                "submissionDate": "2018-09-18",
                "publicReleaseDate": "2019-06-21",
                "people": [
                    {
                        "comments": [],
                        "firstName": "Kim",
                        "lastName": "Kultima",
                        "email": "kim.kultima@medsci.uu.se\n",
                        "affiliation": "Department of Medical Sciences, Clinical Chemistry, Uppsala University",
                        "address": "",
                        "fax": "",
                        "midInitials": "",
                        "phone": "",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "",
                                "termSource": null,
                                "termAccession": ""
                            }
                        ]
                    },
                    {
                        "comments": [],
                        "firstName": "Stephanie",
                        "lastName": "Herman",
                        "email": "stephanie.herman@medsci.uu.se",
                        "affiliation": "Department of Medical Sciences, Clinical Chemistry, Uppsala University",
                        "address": "",
                        "fax": "",
                        "midInitials": "",
                        "phone": "",
                        "roles": [
                            {
                                "comments": [],
                                "annotationValue": "",
                                "termSource": null,
                                "termAccession": ""
                            }
                        ]
                    }
                ],
                "studyDesignDescriptors": [
                    {
                        "comments": [],
                        "annotationValue": "Huntingtin (Huntington disease)",
                        "termSource": {
                            "comments": [],
                            "name": "HRDO",
                            "file": "http://data.bioontology.org/ontologies/HRDO",
                            "version": "2",
                            "description": "Disease core ontology applied to Rare Diseases"
                        },
                        "termAccession": "http://www.limics.org/hrdo/rdfns"
                    },
                    {
                        "comments": [],
                        "annotationValue": "untargeted metabolites",
                        "termSource": {
                            "comments": [],
                            "name": "MTBLS",
                            "file": "https://www.ebi.ac.uk/metabolights/",
                            "version": "1.0",
                            "description": "Metabolights Ontology"
                        },
                        "termAccession": "http://www.ebi.ac.uk/metabolights/ontology/MTBLS_000279"
                    },
                    {
                        "comments": [],
                        "annotationValue": "Liquid Chromatography Mass Spectrometry",
                        "termSource": {
                            "comments": [],
                            "name": "CHMO",
                            "file": "",
                            "version": "2019-06-21",
                            "description": ""
                        },
                        "termAccession": "http://purl.obolibrary.org/obo/CHMO_0000524"
                    }
                ],
                "publications": [
                    {
                        "comments": [],
                        "title": "Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington\u2019s disease subjects",
                        "authorList": "Herman Stephanie, Niemel\u00e4 Valter, Emami Khoonsari Payam, Sundblom Jimmy, Burman Joachim, Landtblom Anne-Marie, Spjuth Ola, Nyholm Dag, Kultima Kim",
                        "pubMedID": "30858393",
                        "doi": "10.1038/s41598-019-40186-5",
                        "status": {
                            "comments": [],
                            "annotationValue": "Published",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "113",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0001796"
                        }
                    }
                ],
                "factors": [
                    {
                        "comments": [],
                        "factorName": "Phenotype",
                        "factorType": {
                            "comments": [],
                            "annotationValue": "phenotype",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "113",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0000651"
                        }
                    },
                    {
                        "comments": [],
                        "factorName": "Replicate",
                        "factorType": {
                            "comments": [],
                            "annotationValue": "replicate",
                            "termSource": {
                                "comments": [],
                                "name": "EFO",
                                "file": "http://data.bioontology.org/ontologies/EFO",
                                "version": "113",
                                "description": "Experimental Factor Ontology"
                            },
                            "termAccession": "http://www.ebi.ac.uk/efo/EFO_0000683"
                        }
                    },
                    {
                        "comments": [],
                        "factorName": "MS format",
                        "factorType": {
                            "comments": [],
                            "annotationValue": "Format",
                            "termSource": {
                                "comments": [],
                                "name": "EDAM",
                                "file": "http://data.bioontology.org/ontologies/EDAM",
                                "version": "19",
                                "description": "EDAM bioinformatics operations, data types, formats, identifiers and topics"
                            },
                            "termAccession": "http://edamontology.org/format_1915"
                        }
                    }
                ],
                "protocols": [
                    {
                        "comments": [],
                        "name": "Sample collection",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Sample collection",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "The lumbar puncture was performed through the L3/L4 or L4/L5 interspace, and CSF was collected in a polypropylene tube that was centrifuged for 5 min at 250 x g at room temperature. The supernatant was transferred, into fresh polypropylene tubes in aliquots of 240 \u00b5L and stored at -80 \u00b0C until analysis.",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Extraction",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Extraction",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "CSF samples were thawed on ice, and 100 \u00b5l was transferred and mixed with 410 \u00b5l ice-cold methanol (MeOH) supplemented with an internal standard cocktail (D4-6keto-prostaglandin-F1-alpha, D4-thromboxane-B2, D4-prostaglandin-F2-alpha, D4-prostaglandin-E2, D4-prostaglandin-D2, D4-15-deoxy-delta12, 14-prostaglandin-J2, D4-cortisol and levonorgestrel) at a final concentration of 0.25 \u00b5M. The samples were further vortexed for 15 s and incubated at -20 \u00b0C for 30 min, followed by centrifugation at 20400 x g for 12 min at 4 \u00b0C. The supernatants were transferred to fresh Eppendorf tubes and dried using a centrifugal vacuum concentrator (overnight).\n\nUpon analysis, the dried samples were reconstituted in 100 \u00b5l of 5% MeOH, 0.1% formic acid (FA) and 94.9% deionized MilliQ water. 10 \u00b5l of each sample was pooled to create a quality control (QC) sample to be injected repeatedly to monitor the performance throughout the analysis.",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Post Extraction",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Derivatization",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Chromatography",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Chromatography",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "The liquid chromatography-mass spectrometry analyses were performed using a Thermo Ultimate 3000 HPLC and Thermo Q-Exactive Orbitrap mass spectrometer. 10 \u00b5l sample was injected to a Thermo Accucore aQ RP C18 column (100 x 2.1 mm, 2.6 \u00b5m particle size). The analytical gradient was initiated with an isocratic flow for 3 min (0% B), followed by a 2.6 min gradient (0-10% B), 8.3 min (10-100% B) and 3 min (100% B), followed, finally, by re-equilibration and washing of the column for 3 min (0% B), where A is 0.1% FA in MilliQ water and B is 89.9% acetonitrile, 10% isopropanol and 0.1% FA.",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Chromatography Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column type",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Column model",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Mass spectrometry",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Mass spectrometry",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "Mass spectrometry data were acquired in profile mode (in positive and negative ionization mode) on a Thermo Q-Exactive Orbitrap mass spectrometer, using a mass range of 70-900 m/z during the first 5 min and 148-900 m/z in the following 15 min (to avoid low mass contaminants) in the positive ionization mode and 70-900 m/z throughout in negative ionization mode. To improve the identification of metabolites, tandem mass spectrometry analyses in positive and negative ionization mode were performed separately on pooled samples containing all samples within a study group (manifest HD, premanifest HD and control).\n\nThe spray voltage on the heated electrospray source was set to 4.0kv and capillary temperature of 350 \u00b0C. The resolution used was set to 70k, the automatic gain control (AGC) target and maximum ion injection time were set to 1e6 and 250 ms, respectively. MS/MS spectra were collected in positive and negative ionization mode where the five most abundant ions were collected using an AGC of 2e5, an isolation width of 1.2 mass over charge (m/z) and fragmented using a normalized collision energy of 30, measured at a resolution of 35k and maximum IT of 250 ms. The exclusion time was set to 20 s.",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan polarity",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Scan m/z range",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Instrument",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Mass analyzer",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            },
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "Ion source",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Data transformation",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Data transformation",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "The acquired raw data was converted to an open source format (mzML). Peaks were centroided by msconvert from ProteoWizard [1] and preprocessed using the following pipeline within the KNIME platform [2]: the peak-picked data was quantified by FeatureFinderMetabo [3] and the resulting features were linked across the samples using featureLinkerUnlabelledQT [4], allowing 10 s retention time tolerance and 5 ppm mass deviation (performed irrespective of charge state across the samples). The non-default parameters used can be found in Table S1.\n\nHowever, the data uploaded herein has only been convetered to mzML.\n\nRef:\n[1] Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neumann S, Gatto L, Fischer B, Pratt B, Egertson J, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nature biotechnology. 2012;30:918\u2013920. doi:10.1038/nbt.2377.\n[2] Berthold MR, Cebron N, Dill F, Gabriel TR, K\u00f6tter T, Meinl T, et al. KNIME: The Konstanz Information Miner. Studies in Classification, Data Analysis, and Knowledge Organization. 2008. page 319\u201326.\n[3] Kenar E, Franken H, Forcisi S, W\u00f6rmann K, H\u00e4ring H-U, Lehmann R. et al. Automated label-free quantification of metabolites from liquid chromatography-mass spectrometry data. Mol Cell Proteomics. 2014;13:348-59. doi:10.1074/mcp.M113.031278.\n[4] Weisser H, Nahnsen S, Grossmann J, Nilse L, Quandt A, Brauer H. et al. An automated pipeline for high-throughput label-free quantitative proteomics. J Proteome Res. 2013;12:1628-44. doi:10.1021/pr300992u.",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    },
                    {
                        "comments": [],
                        "name": "Metabolite identification",
                        "protocolType": {
                            "comments": [],
                            "annotationValue": "Metabolite identification",
                            "termSource": null,
                            "termAccession": ""
                        },
                        "description": "All metabolic features with a 75% coverage across samples were matched against an in house library of characterized metabolites using a 15 ppm mass tolerance and a 20 s time window. Metabolites (identified metabolic features) of interest were manually curated on MS/MS level when available.",
                        "uri": "",
                        "version": "",
                        "parameters": [
                            {
                                "comments": [],
                                "parameterName": {
                                    "comments": [],
                                    "annotationValue": "",
                                    "termSource": null,
                                    "termAccession": ""
                                }
                            }
                        ],
                        "components": []
                    }
                ],
                "assays": [
                    {
                        "comments": [],
                        "measurementType": {
                            "comments": [],
                            "annotationValue": "metabolite profiling",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "22",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000366"
                        },
                        "technologyType": {
                            "comments": [],
                            "annotationValue": "mass spectrometry",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "22",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000470"
                        },
                        "technologyPlatform": "Exactive (Thermo Scientific)",
                        "filename": "a_MTBLS749_LC-MS_negative_reverse-phase_metabolite_profiling.txt",
                        "dataFiles": [],
                        "processSequence": [],
                        "sources": [],
                        "samples": [],
                        "otherMaterials": [],
                        "characteristicCategories": [],
                        "units": [],
                        "graph": null
                    },
                    {
                        "comments": [],
                        "measurementType": {
                            "comments": [],
                            "annotationValue": "metabolite profiling",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "22",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000366"
                        },
                        "technologyType": {
                            "comments": [],
                            "annotationValue": "mass spectrometry",
                            "termSource": {
                                "comments": [],
                                "name": "OBI",
                                "file": "http://data.bioontology.org/ontologies/OBI",
                                "version": "22",
                                "description": "Ontology for Biomedical Investigations"
                            },
                            "termAccession": "http://purl.obolibrary.org/obo/OBI_0000470"
                        },
                        "technologyPlatform": "Liquid Chromatography MS - positive - reverse phase",
                        "filename": "a_MTBLS749_LC-MS_positive_reverse-phase_metabolite_profiling.txt",
                        "dataFiles": [],
                        "processSequence": [],
                        "sources": [],
                        "samples": [],
                        "otherMaterials": [],
                        "characteristicCategories": [],
                        "units": [],
                        "graph": null
                    }
                ],
                "sources": [],
                "samples": [],
                "processSequence": [],
                "characteristicCategories": [],
                "units": []
            }
        ]
    },
    "validation": {
        "errors": [],
        "warnings": []
    }
}